Moody’s also affirmed Doylestown’s “Baa2” ratings, affecting $60.6 million of rated debt. The rating affirmation is based on several factors, including Doylestown’s strong market position and proactive management team.
The rating revision is based on Doylestown’s recent weaker-than-expected operating performance, which exacerbates its investment losses.
More articles on healthcare finance:
Mercer Health plans $24M expansion
Indiana radiology group selects McKesson for RCM services
5 ways to build your case for inventory management technology
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.